Halime Kalkavan
Impact in
- Immunology top 10%
- Phagocytosis and Immune Regulation
- interferon and immune responses
- Immune cells in cancer
- Cancer Research top 10%
Papers in
-
- Cell death mechanisms and regulation 5
- DNA Repair Mechanisms 1
- Oncology 6
- Cancer Immunotherapy and Biomarkers 2
- Cancer Cells and Metastasis 2
- Co-authors
- Douglas R. Green (8 shared papers)Jeremy Chase Crawford (3 shared papers)Giovanni Quarato (3 shared papers)Patrick Fitzgerald (2 shared papers)Jinan Chen (2 shared papers)Colin R. Goding (2 shared papers)Stephen W. G. Tait (1 shared paper)Charles Gawad (1 shared paper)
- Journals
- Cell (2 papers)Cellular Physiology and Biochemistry (2 papers)Nature Cancer (1 paper)Proceedings of the National Academy of Sciences (1 paper)Pigment Cell & Melanoma Research (1 paper)
- Partner nations
- GermanyUnited StatesUnited Kingdom
In The Last Decade
Halime Kalkavan
14 papers receiving 1.2k citations
Halime Kalkavan's Hit Papers
Peers
Comparison fields: 5 of 91
- Immunology 293
- Cancer Research 156
- Molecular Biology 693
- Epidemiology 237
- Oncology 176
Countries citing papers authored by Halime Kalkavan
This map shows the geographic impact of Halime Kalkavan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Halime Kalkavan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Halime Kalkavan more than expected).
Fields of papers citing papers by Halime Kalkavan
This network shows the impact of papers produced by Halime Kalkavan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Halime Kalkavan. The network helps show where Halime Kalkavan may publish in the future.
Co-authors
The 25 scholars most cited alongside Halime Kalkavan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | MOMP, cell suicide as a BCL-2 family business Hit paper breakdown → | 2017 | 527 |
| 2 | 2018 | 246 | |
| 3 | Sublethal cytochrome c release generates drug-tolerant persister cells Hit paper breakdown → | 2022 | 155 |
| 4 | 2023 | 59 | |
| 5 | 2022 | 48 | |
| 6 | 2018 | 37 | |
| 7 | 2014 | 36 | |
| 8 | 2023 | 29 | |
| 9 | 2019 | 27 | |
| 10 | 2015 | 18 | |
| 11 | 2016 | 10 | |
| 12 | 2016 | 5 | |
| 13 | 2011 | 4 | |
| 14 | 2025 | 1 | |
| 15 | 2024 | 0 | |
| 16 | 2025 | 0 | |
| 17 | 2025 | 0 | |
| 18 | 2025 | 0 |
About Halime Kalkavan
Halime Kalkavan is a scholar working on Molecular Biology, Oncology, Epidemiology, Immunology and Pulmonary and Respiratory Medicine, having authored 18 papers that have together received 1.2k indexed citations. Recurring topics across this work include Cell death mechanisms and regulation (5 papers), Autophagy in Disease and Therapy (5 papers), Phagocytosis and Immune Regulation (3 papers), Cancer Immunotherapy and Biomarkers (2 papers), Cancer Cells and Metastasis (2 papers), Cancer, Stress, Anesthesia, and Immune Response (2 papers), DNA Repair Mechanisms (1 paper) and Cancer Genomics and Diagnostics (1 paper). The work is most often cited by research in Immunology (293 citations), Cancer Research (156 citations), Molecular Biology (693 citations), Epidemiology (237 citations) and Oncology (176 citations). Halime Kalkavan has collaborated with scholars based in Germany, United States and United Kingdom. Frequent co-authors include Douglas R. Green, Jeremy Chase Crawford, Giovanni Quarato, Patrick Fitzgerald, Jinan Chen, Colin R. Goding, Stephen W. G. Tait, Charles Gawad, Meghan E. Turnis and Michael D. L. Johnson. Their work appears in journals such as Cell, Cellular Physiology and Biochemistry, Nature Cancer, Proceedings of the National Academy of Sciences and Pigment Cell & Melanoma Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.